Showing results (1561-1570 of 1,573) with videos related to
Sort By:
Pageof 158
Journal of the National Cancer Institute|December 9, 2014
Germline mutations in shelterin complex genes are associated with familial gliomaMatthew N Bainbridge, Georgina N Armstrong, M Monica Gramatges, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatmentJ S Whelan, S S Bielack, N Marina, et al.Stroke|May 16, 2013
17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke statusPoneh Adib-Samii, Natalia Rost, Matthew Traylor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.Nature|June 23, 2012
Novel mutations target distinct subgroups of medulloblastomaGiles Robinson, Matthew Parker, Tanya A Kranenburg, et al.Cell|January 30, 2016
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaMichele Ceccarelli, Floris P Barthel, Tathiane M Malta, et al.Science Signaling|June 4, 2020
The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cellsCesar A Corzo, Eugene Varfolomeev, A Francesca Setiadi, et al.European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.Acta Neuropathologica|May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entityTara Spence, Patrick Sin-Chan, Daniel Picard, et al.The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.Pageof 158